Dennis Gillings, founder and chief executive officer of Quintiles, says “bad human behavior” and the need to treat it will drive future growth in the pharmaceutical industry.

Speaking at the Forbes Global CEO conference in Australia on Friday, Gillings pointed out treatments for diseases such as type 2 diabetes as well as cosmetics will drive demand.

"You’ll see technology off-setting bad human behavior,” The Australian newspaper “You can argue that that’s not good but the reality is that’s what’s happening.

"Humans like to indulge and they like to look beautiful,” he added. “Human nature will generate many of these products."

Quintiles is the world’s largest life sciences services provider for biotech and pharmaceutical firms, offering partnerships in drug development, clinical trial management and investments.

Gillings made headlines earlier this week when he told Bloomberg news that the Research Triangle Park-based firm

Get the latest news alerts: at Twitter.